Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α2a in MHCC97 Cells

Publisher： Karger

E-ISSN： 1423-0232|67|5-6|428-440

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.5-6, 2005-02, pp. : 428-440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bcl‐2 Antagonists Kill Plasmacytoid Dendritic Cells From Lupus‐Prone Mice and Dampen Interferon‐α Production

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 3, 2015-03 ,pp. : 797-808

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expansion of circulating CD56bright natural killer cells in patients with JAK2‐positive chronic myeloproliferative neoplasms during treatment with interferon‐α

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 227-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Recombinant Interferon-α2a and Interferon-αA/D Have Different Effects on Bleomycin-Induced Lung Injury

By  

Respiration, Vol. 68, Iss. 2, 2001-03 ,pp. : 169-177

Karger

Access to resources Recommend Favorite

Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK

By              

International Journal of Molecular Medicine, Vol. 34, Iss. 4, 2014-01 ,pp. : 1081-1086

Spandidos Publications

Access to resources Recommend Favorite

Neutralizing anti‐interferon‐α antibodies and response to treatment in patients with Ph+ chronic myeloid leukaemia sequentially treated with recombinant (α2a) and lymphoblastoid interferon‐α

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 300-305

John Wiley & Sons Inc

Access to resources Recommend Favorite